Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024

変形性関節症治療法の世界市場予測(~2024年)

◆タイトル:Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024
◆商品コード:PH 7393
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年10月22日
◆ページ数:148
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、変形性関節症治療法の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、解剖学別(膝、股関節)分析、薬物種類別(NSAID、コルチコステロイド)分析、投与経路別(非経口、局所)分析、流通チャンネル別(病院薬局)分析、変形性関節症治療法の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、変形性関節症治療法の世界市場規模が2019年68億ドルから2024年101億ドルまで年平均8.1%成長すると予測しています。

“The osteoarthritis therapeutics market is projected to register a CAGR of 8.1% during the forecast period.”The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 8.1%. Growth in this industry is driven by the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. On the other hand, the availability of alternative non-drug pain management therapies is a major market challenge.

“Knee osteoarthritis segment to witness the highest growth during the forecast period.”
Based on anatomy, the osteoarthritis therapeutics market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment is projected to grow at the highest CAGR during the forecast period. A large number of patients suffering from knee osteoarthritis is the major factor supporting the growth of this segment.

“Viscosupplementation agents segment to register the highest growth in the osteoarthritis therapeutics market during the forecast period.”
Based on drug type, the osteoarthritis therapeutics market is segmented into viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. The analgesics segment is sub-segmented into duloxetine and acetaminophen, while the NSAIDs segment is sub-segmented into naproxen, aspirin, diclofenac, ibuprofen, and other molecules. The viscosupplementation agents segment is projected to witness the highest growth in the osteoarthritis therapeutics market during the forecast period. The rising incidence of knee osteoarthritis is one of the major factors supporting the growth of this segment.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the osteoarthritis therapeutics market is segmented into four major regional segments, namely, Europe, North America, Asia Pacific, and the Rest of the World (RoW). The market in Asia-Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is driven primarily by the rising incidence and prevalence of osteoarthritis, increasing geriatric and obese populations, and healthcare infrastructure improvements in several APAC countries.

Breakdown of Profiles of Primary Participants:
• By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
• By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
• By Region: North America: 35%, Europe: 24%, Asia Pacific: 25%, and the Rest of the World: 16%

Key players in the osteoarthritis therapeutics market include Sanofi (France), Horizon Therapeutics (Ireland), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Bayer AG (Germany), Abbott (US), Pfizer (US), Eli Lilly (US), Anika Therapeutics (US), and Flexion Therapeutics (US).

Research Coverage:
The report analyzes the osteoarthritis therapeutics market by anatomy, drug type, route of administration, distribution channel, purchasing pattern, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one, or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the osteoarthritis therapeutics market
• Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the osteoarthritis therapeutics market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the osteoarthritis therapeutics market
• Market Development: Detailed information about emerging markets. The report analyzes the market for various osteoarthritis therapeutics across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the osteoarthritis therapeutics market

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Osteoarthritis Therapeutics Market Overview
4.2 Europe: Market Share, By Anatomy (2018)
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in the Geriatric and Obese Populations and the Associated Increase in the Prevalence of Osteoarthritis
5.2.1.2 Increasing Incidence of Sports Injuries
5.2.2 Restraints
5.2.2.1 Risk of Adverse Cardiovascular Events Associated With the Use of Nsaids in Osteoarthritis Treatment
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Strategic Collaborations Focused on New Product Development
5.2.4 Challenges
5.2.4.1 Availability of Alternative Non-Drug Pain Management Therapies
6 Osteoarthritis Therapeutics Market, By Anatomy (Page No. – 39)
6.1 Introduction
6.2 Knee Osteoarthritis
6.2.1 Rising Obese and Geriatric Populations to Increase the Prevalence of Knee Osteoarthritis
6.3 Hip Osteoarthritis
6.3.1 Similar to Knee Osteoarthritis, Hip Osteoarthritis is More Common in the Geriatric and Obese Populations
6.4 Hand Osteoarthritis
6.4.1 Rising Prevalence of Shoulder Osteoarthritis to Drive Market Growth
6.5 Small-Joint Osteoarthritis
6.5.1 Rising Number of Ankle-Related Sports Injuries to Increase the Prevalence of Ankle Osteoarthritis
7 Osteoarthritis Therapeutics Market, By Drug Type (Page No. – 45)
7.1 Introduction
7.2 Viscosupplementation Agents
7.2.1 Viscosupplementation Agents Dominated the Market in 2018
7.3 Nonsteroidal Anti-Inflammatory Drugs
7.3.1 Nsaids Can Relieve Pain and Inflammation Without the Various Potential Adverse Effects Associated With Corticosteroids
7.3.1.1 Ibuprofen
7.3.1.2 Diclofenac
7.3.1.3 Aspirin
7.3.1.4 Naproxen
7.3.1.5 Other Molecules
7.4 Analgesics
7.4.1 Acetaminophen
7.4.2 Duloxetine
7.5 Corticosteroids
8 Osteoarthritis Therapeutics Market, By Route of Administration (Page No. – 54)
8.1 Introduction
8.2 Oral Route
8.3 Parenteral Route
8.4 Topical Route
9 Osteoarthritis Therapeutics Market, By Distribution Channel (Page No. – 58)
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Online Pharmacies
9.4 Retail Pharmacies
10 Osteoarthritis Therapeutics Market, By Purchasing Pattern (Page No. – 62)
10.1 Introduction
10.2 Prescription Drugs
10.2.1 Prescription Drugs to Account for A Larger Share of the Market
10.3 Over-The-Counter Drugs
10.3.1 Ease of Purchase and Administration Resulting in A Rising Demand for Otc Drugs
11 Osteoarthritis Therapeutics Market, By Region (Page No. – 65)
11.1 Introduction
11.2 Europe
11.2.1 Italy
11.2.2 Germany
11.2.3 Spain
11.2.4 France
11.2.5 UK
11.2.6 Rest of Europe
11.3 North America
11.3.1 US
11.3.2 Canada
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of Asia Pacific
11.5 Rest of the World
12 Competitive Landscape (Page No. – 115)
12.1 Overview
12.2 Market Ranking Analysis, 2018
12.3 Competitive Scenario
12.3.1 Product Launches and Approvals, 2016–2019
12.3.2 Collaborations, 2016–2019
12.3.3 Expansions, 2016–2019
12.3.4 Acquisitions, 2016–2019
12.3.5 Other Developments
12.4 Competitive Leadership Mapping
12.4.1 Vendor Inclusion Criteria
12.4.2 Visionary Leaders
12.4.3 Innovators
12.4.4 Dynamic Differentiators
12.4.5 Emerging Companies
13 Company Profiles (Page No. – 120)
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.1 Sanofi
13.2 Horizon Therapeutics PLC
13.3 Johnson & Johnson
13.4 Glaxosmithkline PLC
13.5 Bayer AG
13.6 Abbott
13.7 Pfizer, Inc.
13.8 Eli Lilly
13.9 Anika Therapeutics, Inc.
13.10 Novartis
13.11 Ferring Pharmaceuticals
13.12 Bioventus
13.13 Zimmer Biomet Holdings, Inc.
13.14 Fidia Farmaceutici S.P.A.
13.15 Flexion Therapeutics, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. – 141)
14.1 Discussion Guide
14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details

List of Tables (146 Tables)
Table 1 Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
Table 2 Knee Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 3 Hip Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 4 Hand Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 5 Small-Joint Osteoarthritis Therapeutics Market, By Region, 2017–2024 (USD Million)
Table 6 Market, By Drug Type, 2017–2024 (USD Million)
Table 7 Market for Viscosupplementation Agents, By Region, 2017–2024 (USD Million)
Table 8 Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 9 Market for Nonsteroidal Anti-Inflammatory Drugs, By Region, 2017–2024 (USD Million)
Table 10 Market for Ibuprofen, By Region, 2017–2024 (USD Million)
Table 11 Market for Diclofenac, By Region, 2017–2024 (USD Million)
Table 12 Market for Aspirin, By Region, 2017–2024 (USD Million)
Table 13 Market for Naproxen, By Region, 2017–2024 (USD Million)
Table 14 Market for Other Molecules, By Region, 2017–2024 (USD Million)
Table 15 Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 16 Market for Analgesics, By Region, 2017–2024 (USD Million)
Table 17 Market for Acetaminophen, By Region, 2017–2024 (USD Million)
Table 18 Market for Duloxetine, By Region, 2017–2024 (USD Million)
Table 19 Market for Corticosteroids, By Region, 2017–2024 (USD Million)
Table 20 Market, By Route of Administration, 2017–2024 (USD Million)
Table 21 Market for Oral Route of Administration, By Region, 2017–2024 (USD Million)
Table 22 Market for Parenteral Route of Administration, By Region, 2017–2024 (USD Million)
Table 23 Market for Topical Route of Administration, By Region, 2017–2024 (USD Million)
Table 24 Market, By Distribution Channel, 2017–2024 (USD Million)
Table 25 Market for Hospital Pharmacies, By Region, 2017–2024 (USD Million)
Table 26 Market for Online Pharmacies, By Region, 2017–2024 (USD Million)
Table 27 Market for Retail Pharmacies, By Region, 2017–2024 (USD Million)
Table 28 Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 29 Market for Prescription Drugs, By Region, 2017–2024 (USD Million)
Table 30 Market for Over-The-Counter Drugs, By Region, 2017–2024 (USD Million)
Table 31 Market, By Region, 2017–2024 (USD Million)
Table 32 Europe: Market, By Country, 2017–2024 (USD Million)
Table 33 Europe: Market, By Anatomy, 2017–2024 (USD Million)
Table 34 Europe: Market, By Drug Type, 2017–2024 (USD Million)
Table 35 Europe: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 36 Europe: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 37 Europe: Market, By Route of Administration, 2017–2024 (USD Million)
Table 38 Europe: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 39 Europe: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 40 Italy: Market, By Anatomy, 2017–2024 (USD Million)
Table 41 Italy: Market, By Drug Type, 2017–2024 (USD Million)
Table 42 Italy: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 43 Italy: Osteoarthritis Therapeutics Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 44 Italy: Market, By Route of Administration, 2017–2024 (USD Million)
Table 45 Italy: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 46 Italy: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 47 Germany: Market, By Anatomy, 2017–2024 (USD Million)
Table 48 Germany: Market, By Drug Type, 2017–2024 (USD Million)
Table 49 Germany: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 50 Germany: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 51 Germany: Market, By Route of Administration, 2017–2024 (USD Million)
Table 52 Germany: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 53 Germany: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 54 Spain: Market, By Anatomy, 2017–2024 (USD Million)
Table 55 Spain: Market, By Drug Type, 2017–2024 (USD Million)
Table 56 Spain: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 57 Spain: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 58 Spain: Market, By Route of Administration, 2017–2024 (USD Million)
Table 59 Spain: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 60 Spain: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 61 France: Market, By Anatomy, 2017–2024 (USD Million)
Table 62 France: Market, By Drug Type, 2017–2024 (USD Million)
Table 63 France: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 64 France: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 65 France: Market, By Route of Administration, 2017–2024 (USD Million)
Table 66 France: Osteoarthritis Therapeutics Market, By Distribution Channel, 2017–2024 (USD Million)
Table 67 France: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 68 UK: Market, By Anatomy, 2017–2024 (USD Million)
Table 69 UK: Market, By Drug Type, 2017–2024 (USD Million)
Table 70 UK: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 71 UK: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 72 UK: Market, By Route of Administration, 2017–2024 (USD Million)
Table 73 UK: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 74 UK: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 75 RoE: Market, By Anatomy, 2017–2024 (USD Million)
Table 76 RoE: Market, By Drug Type, 2017–2024 (USD Million)
Table 77 RoE: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 78 RoE: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 79 RoE: Market, By Route of Administration, 2017–2024 (USD Million)
Table 80 RoE: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 81 RoE: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 82 North America: Market, By Country, 2017–2024 (USD Million)
Table 83 North America: Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
Table 84 North America: Market, By Drug Type, 2017–2024 (USD Million)
Table 85 North America: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 86 North America: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 87 North America: Market, By Route of Administration, 2017–2024 (USD Million)
Table 88 North America: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 89 North America: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 90 US: Market, By Anatomy, 2017–2024 (USD Million)
Table 91 US: Market, By Drug Type, 2017–2024 (USD Million)
Table 92 US: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 93 US: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 94 US: Market, By Route of Administration, 2017–2024 (USD Million)
Table 95 US: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 96 US: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 97 Canada: Market, By Anatomy, 2017–2024 (USD Million)
Table 98 Canada: Market, By Drug Type, 2017–2024 (USD Million)
Table 99 Canada: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 100 Canada: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 101 Canada: Market, By Route of Administration, 2017–2024 (USD Million)
Table 102 Canada: Osteoarthritis Therapeutics Market, By Distribution Channel, 2017–2024 (USD Million)
Table 103 Canada: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 104 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 105 Asia Pacific: Market, By Anatomy, 2017–2024 (USD Million)
Table 106 Asia Pacific: Market, By Drug Type, 2017–2024 (USD Million)
Table 107 Asia Pacific: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 108 Asia Pacific: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 109 Asia Pacific: Market, By Route of Administration, 2017–2024 (USD Million)
Table 110 Asia Pacific: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 111 Asia Pacific: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 112 Japan: Market, By Anatomy, 2017–2024 (USD Million)
Table 113 Japan: Market, By Drug Type, 2017–2024 (USD Million)
Table 114 Japan: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 115 Japan: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 116 Japan: Market, By Route of Administration, 2017–2024 (USD Million)
Table 117 Japan: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 118 Japan: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 119 China: Osteoarthritis Therapeutics Market, By Anatomy, 2017–2024 (USD Million)
Table 120 China: Market, By Drug Type, 2017–2024 (USD Million)
Table 121 China: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 122 China: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 123 China: Market, By Route of Administration, 2017–2024 (USD Million)
Table 124 China: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 125 China: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 126 India: Market, By Anatomy, 2017–2024 (USD Million)
Table 127 India: Market, By Drug Type, 2017–2024 (USD Million)
Table 128 India: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 129 India: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 130 India: Market, By Route of Administration, 2017–2024 (USD Million)
Table 131 India: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 132 India: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 133 RoAPAC: Market, By Anatomy, 2017–2024 (USD Million)
Table 134 RoAPAC: Market, By Drug Type, 2017–2024 (USD Million)
Table 135 RoAPAC: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 136 RoAPAC: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 137 RoAPAC: Osteoarthritis Therapeutics Market, By Route of Administration, 2017–2024 (USD Million)
Table 138 RoAPAC: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 139 RoAPAC: Market, By Purchasing Pattern, 2017–2024 (USD Million)
Table 140 RoW: Market, By Anatomy, 2017–2024 (USD Million)
Table 141 RoW: Market, By Drug Type, 2017–2024 (USD Million)
Table 142 RoW: Market for Analgesics, By Type, 2017–2024 (USD Million)
Table 143 RoW: Market for Nonsteroidal Anti-Inflammatory Drugs, By Molecule, 2017–2024 (USD Million)
Table 144 RoW: Market, By Route of Administration, 2017–2024 (USD Million)
Table 145 RoW: Market, By Distribution Channel, 2017–2024 (USD Million)
Table 146 RoW: Market, By Purchasing Pattern, 2017–2024 (USD Million)

List of Figures (34 Figures)
Figure 1 Osteoarthritis Therapeutics Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market: Bottom-Up Approach
Figure 5 Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Anatomy, 2019 vs 2024 (USD Billion)
Figure 8 Market, By Drug Type, 2019 vs 2024 (USD Billion)
Figure 9 Market, By Route of Administration, 2019 vs 2024 (USD Billion)
Figure 10 Osteoarthritis Therapeutics Market, By Distribution Channel, 2019 vs 2024 (USD Billion)
Figure 11 Market, By Purchasing Pattern, 2019 vs 2024 (USD Billion)
Figure 12 Market, By Region, 2019 vs 2024 (USD Billion)
Figure 13 High and Growing Prevalence of Osteoarthritis is the Major Factor Driving the Growth of This Market
Figure 14 Knee Osteoarthritis Therapeutics Segment to Dominate the European Market in 2019
Figure 15 China to Register the Highest CAGR During the Forecast Period
Figure 16 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Geriatric Population, By Region, 2017 vs 2050
Figure 18 Europe: Osteoarthritis Therapeutics Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 Key Developments in the Market From January 2016 to August 2019
Figure 21 Top 5 Companies in the Market
Figure 22 Global Market: Competitive Leadership Mapping, 2019
Figure 23 Sanofi: Company Snapshot (2018)
Figure 24 Horizon Therapeutics PLC: Company Snapshot (2018)
Figure 25 Johnson & Johnson: Company Snapshot (2018)
Figure 26 Glaxosmithkline PLC: Company Snapshot
Figure 27 Bayer AG: Company Snapshot (2018)
Figure 28 Abbott: Company Snapshot (2018)
Figure 29 Pfizer, Inc.: Company Snapshot (2018)
Figure 30 Eli Lilly: Company Snapshot (2018)
Figure 31 Anika Therapeutics, Inc.: Company Snapshot (2018)
Figure 32 Novartis: Company Snapshot (2018)
Figure 33 Zimmer Biomet Holdings, Inc.: Company Snapshot (2018)
Figure 34 Flexion Therapeutics: Company Snapshot (2018)

★調査レポート[変形性関節症治療法の世界市場予測(~2024年)] ( Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024 / PH 7393) 販売に関する免責事項
[変形性関節症治療法の世界市場予測(~2024年)] ( Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024 / PH 7393) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆